Meanwhile, SIRT4, as a downstream target of the epigenetic regulator UHRF1, antagonizes the HIF-1α-mediated transcription of glycolytic genes, thereby inhibiting glycolysis, tumor proliferation, and metastasis. Here, SIRT4 is linked to neoplasm.